Sofinnova Ventures »

Celcuity shares owned by Sofinnova Ventures

Quarter-by-quarter ownership of Celcuity (CELC) shares owned by Sofinnova Ventures from 13F filings

Historical chart of Sofinnova Ventures investment in Celcuity

Tip: Access up to 7 years of quarterly data

All positions including Celcuity held by Sofinnova Ventures consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celcuity by Sofinnova Ventures

Quarter filed Position value Share count Share price at filing
2025-09-30 $13M 253k 49.40

More positions owned by Sofinnova Ventures

Natera (NTRA)
Gilead Sciences (GILD)
United Therapeutics Corporation Put Option (UTHR)
Vera Therapeutics Cl A (VERA)
Jazz Pharmaceuticals Shs Usd (JAZZ)
AstraZeneca Sponsored Adr (AZN)
Rapport Therapeutics (RAPP)
Boston Scientific Corporation (BSX)
Uniqure NV SHS Call Option (QURE)
Dex (DXCM)
Intuitive Surgical (ISRG)
Axsome Therapeutics (AXSM)
Roivant Sciences SHS (ROIV)
iShares TR Ishares Biotech Put Option (IBB)
Vertex Pharmaceuticals Incorporated (VRTX)

View all positions for Sofinnova Ventures

Top funds holding Celcuity

Baker Bros. Advisors
Perceptive Advisors
BlackRock
NEA Management Company
Vanguard Group
Soleus Capital Management
Tang Capital Management
Eventide Asset Management
UBS Group
Sio Capital Management
Morgan Stanley
Apis Capital Advisors
Geode Capital Management
Deerfield Management Company
State Street Corporation

View all funds holding Celcuity